SFRP4 and breast cancer: We identified eight CAF subtypes that demonstrate different expression patterns, in which a new CAF subtype that specifically expresses the secreted frizzled-related protein 4 (SFRP4) and has a significantly higher composition in normal tissue, may inhibit BC progression by inhibiting the WNT signaling pathway.